LobbyingPharmaceutical Distribution Security Alliance lobbying by quarter
Pharmaceutical Distribution Security Alliance's latest lobbying report covers Q4 2025, at under $5,000. Its first report covers Q1 2017; the issues it reports most are Health Issues.
Pharmaceutical Distribution Security Alliance
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2017
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2017 | $0 | 1 |
| Q2 2017 | $0 | 0 |
| Q3 2017 | $0 | 0 |
| Q4 2017 | $0 | 0 |
| Q1 2018 | $0 | 0 |
| Q2 2018 | $0 | 0 |
| Q3 2018 | $0 | 0 |
| Q4 2018 | $0 | 1 |
| Q1 2019 | $0 | 1 |
| Q2 2019 | $0 | 0 |
| Q3 2019 | $0 | 0 |
| Q4 2019 | $20K | 1 |
| Q1 2020 | $0 | 1 |
| Q2 2020 | $0 | 0 |
| Q3 2020 | $0 | 1 |
| Q4 2020 | $0 | 0 |
| Q1 2021 | $0 | 0 |
| Q2 2021 | $0 | 0 |
| Q3 2021 | $0 | 0 |
| Q4 2021 | $0 | 0 |
| Q1 2022 | $10K | 1 |
| Q2 2022 | $0 | 0 |
| Q3 2022 | $0 | 0 |
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $10K | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$50K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)4 reports
- Health & Human Services, Dept of (HHS)4 reports
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
- White House Office4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Leavitt Partners | $50K | 20 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| VINCE VENTIMIGLIA jr | Assistant Secretary for Legislation - HHS; Legislative Assistant - Senate; Counsel and Law Clerk - US Administrative Office; Counsel - Senate; Policy Director - Senate. | Q1 2022 |
| ANNE MARIE LAUTERBACH | Legislative Correspondent for Rep. Mike Ferguson | Q4 2019 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 01/09for Q4 2025 | Leavitt Partners | Under $5,000 |
| 25/10/20for Q3 2025 | Leavitt Partners | Under $5,000 |
| 25/07/15for Q2 2025 | Leavitt Partners | Under $5,000 |
| 25/04/17for Q1 2025 | Leavitt Partners | Under $5,000 |
| 25/01/15for Q4 2024 | Leavitt Partners | Under $5,000 |
| 24/10/16for Q3 2024 | Leavitt Partners | Under $5,000 |
| 24/07/22for Q2 2024 | Leavitt Partners | Under $5,000 |
| 24/04/16for Q1 2024 | Leavitt Partners | Under $5,000 |
| 24/01/10for Q4 2023 | Leavitt Partners | Under $5,000 |
| 23/10/25for Q4 2022 | Leavitt Partners | Under $5,000 |
| 23/10/25for Q1 2022 | Leavitt Partners | $10K |
| 23/10/25for Q4 2019 | Leavitt Partners | $20K |
| 23/10/25for Q3 2020 | Leavitt Partners | Under $5,000 |
| 23/10/25for Q1 2020 | Leavitt Partners | Under $5,000 |
| 23/10/25for Q4 2019 | Leavitt Partners | $20K |
| 23/10/25for Q1 2019 | Leavitt Partners | Under $5,000 |
| 23/10/25for Q4 2018 | Leavitt Partners | Under $5,000 |
| 23/10/25for Q1 2017 | Leavitt Partners | Under $5,000 |
| 23/10/20for Q3 2023 | Leavitt Partners | $10K |
| 23/07/20for Q2 2023 | Leavitt Partners | $10K |